Skip to main content
SpringerLink
Log in

The obviousness rejection as a barrier to biotech patent prosecution

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An analysis of US Federal Circuit decisions shows the effects of the Supreme Court's decision in KSR v. Teleflex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Ruiz v. A.B. Chance Co. 234 F.3d 654 (Fed. Cir. 2000).

  2. In re Dembiczak 175 F3.d 994 (Fed. Cir. 1999).

  3. In re Kotzab 217 F.3d 1365, 1371 (Fed. Cir. 2000).

  4. KSR Int'l Co. v. Teleflex, Inc. 550 US 398 (2007).

  5. Wong, H.K. & Lau, D. Nat. Biotechnol. 27, 446–448 (2009).

    Article  CAS  Google Scholar 

  6. Takeda Chem. Indus., Ltd. v. Alphapharm Pty., Ltd. 492 F.3d 1350 (Fed. Cir. 2007).

  7. Pharmastem Therapeutics, Inc. v. Viacell, Inc., et al. 491 F.3d 1342 (Fed. Cir. 2007).

  8. In re Kubin __ F.3d __, No. 2008-1184 (Fed. Cir. 2009).

  9. Pfizer, Inc. v. Apotex, Inc. 480 F.3d 1348 (Fed. Cir. 2007).

  10. In re Peterson 315 F.3d 1325 (Fed. Cir. 2003).

  11. WMS Gaming, Inc. v. Int'l Game Tech. 184 F.3d 1339 (Fed. Cir. 1999).

Download references

Acknowledgements

This study was supported by the National Science Council, Taiwan, Republic of China (grant no. NSC 96-2414-H-075-001), Taipei Veterans General Hospital project (V98C1-190) and Committee on Chinese Medicine and Pharmacy (CCMP97-RD-117). The author would also like thank I.T. Huang, for summarizing the CAFC ruling and H.C. Lee for the statistical analysis.

Author information

Authors and Affiliations

  1. Shyh-Jen Wang is in the Division of Experimental Surgery, Department of Surgery, Taipei Veterans General Hospital and the Institute of Biomedical Engineering, National Yang-Ming University, Taipei, Taiwan, Republic of China.,

    Shyh-Jen Wang

Authors
  1. Shyh-Jen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shyh-Jen Wang.

Supplementary information

Supplementary Text and Figures

Supplementary Table 1 (PDF 252 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SJ. The obviousness rejection as a barrier to biotech patent prosecution. Nat Biotechnol 27, 1125–1126 (2009). https://doi.org/10.1038/nbt1209-1125

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1209-1125

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation